Skip to search formSkip to main contentSkip to account menu

DHAP Regimen

Known as: Dexamethasone-High Dose AraC-Platinol Regimen 
A chemotherapy regimen consisting of dexamethasone, high-dose cytarabine (Ara-C) and cisplatin, used to treat relapsed and refractory non-Hodgkin's… 
National Institutes of Health

Related topics

Related topics

6 relations
CisplatinCytarabineDHAP protocolDexamethasone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
R‐DHA‐oxaliplatin (R‐DHAOx) versus R‐DHA‐cisplatin (R‐DHAP) regimen in B‐cell lymphoma treatment: A eight‐year trajectory study
The R‐DHAP regimen (rituximab, cisplatin, dexamethasone, and high‐dose cytarabine) is standardly used to treat relapsed Non… 
2012
2012
Clinical study of DHAP regimen for patients with relapsed or refractory in the treatment of advanced non-Hodgkin's lymphoma
Objective This study was to observe the efficacy and toxicity of DH AP regimen for the patient with relapse or refractory… 
2011
2011
Relapsed diffuse large B-cell lymphoma: clinical utility of cell of origin.
Although cases of diffuse large B-cell lymphoma (DLBCL) may look identical under the microscope, DLBCL is a clinically and… 
2008
2008
Who should receive myeloablative therapy for diffuse large B-cell lymphoma?
Over half of all newly-diagnosed diffuse large B-cell lymphoma patients can be cured with first line treatment based on the… 
2008
2008
R-DHAP: A good small step, but not the journey's end
The DHAP regimen (dexamethasone, cytarabine, cisplatin) was first reported in 1988 as an effective lymphoma salvage regimen [1… 
2006
2006
Clinical study of DHAP regimen for patients with relapsed or refractory in the treatment of advanced non-Hodgkin’s lymphoma
This study was to observe the efficacy and toxicity of DHAP regimen for the patient with relapse or refractory advanced non… 
2005
2005
Effects of DHAP Regimen in Treatment of Relapsing and Refractory Non-Hodgkin’s Lymphoma
Objective To evaluate the clinical results of DHAP regimen in treatment of relapsing and refractory non-Hodgkin’s lymphoma… 
2002
2002
[Preliminary study on DHAP regimen for patients with relapsed and refractory non-Hodgkin's lymphoma].
BACKGROUND AND OBJECTIVE The treatment of the patients with relapsed and refractory non-Hodgkin's lymphoma(NHL) remains difficult… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)